atrial implantation devices

By implanting a pacemaker into the atrial septum and combining it with shunt or occlusion structures, the problem of pacemaker syndrome associated with traditional ventricular pacemakers has been solved, achieving efficient, safe, and low-cost atrial pacing treatment.

CN116407772BActive Publication Date: 2026-11-10UNITED INNOMED (SHANGHAI) LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202111678181.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-12-31
Publication Date
2026-11-10
Estimated Expiration
2041-12-31

AI Technical Summary

Technical Problem

Pacemaker syndrome caused by traditional ventricular pacing devices limits the widespread use of leadless pacing technology, and traditional cardiac pacing devices require separate anchoring devices, which increases cardiac tissue damage and treatment costs.

Method used

Design an atrial implantation device that uses an anchoring device to anchor the pacing device housing to the atrial septum and delivers pacing pulses directly through electrodes in contact with the atrial septum. Combined with shunt, occlusion, or mesh structure, atrial pacing can be achieved, simplifying the structure and reducing damage to the heart and treatment costs.

Benefits of technology

It achieves better atrial pacing effect, reduces the risk of thrombosis and adverse reactions, simplifies the equipment structure, and reduces treatment costs and cardiac tissue damage.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116407772B_ABST
    Figure CN116407772B_ABST
Patent Text Reader

Abstract

This application provides an atrial implantation device. The atrial implantation device includes: a pacing device comprising a pulse generating module, a first electrode, and a housing, wherein the pulse generating module is housed within the housing, the first electrode is configured to contact an atrial septum, and the pulse generating module is configured to deliver pacing pulses to the atrial septum through the first electrode; and an anchoring device configured to anchor the housing to the atrial septum. The atrial implantation device provided by this application utilizes the anchoring device to anchor the housing of the pacing device to the patient's atrial septum, and utilizes the electrode in contact with the atrial septum to directly deliver pacing pulses to the patient's atrial septum. In this way, leadless atrial pacing can be achieved, and the pacing effect is superior.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This application relates to the field of medical device technology, specifically to an atrial implantation device. Background Technology

[0002] Among internal medicine diseases, heart disease is the most common. It can significantly affect a patient's ability to work, greatly reduce their quality of life, and seriously threaten their life.

[0003] Certain heart conditions can cause a slow heartbeat, or even cardiac arrest. The most common treatment for slow heartbeats or cardiac arrest is the implantation of a pacemaker.

[0004] Traditional cardiac pacing devices typically involve implanting two electrodes in the atrium and ventricle of the heart to achieve dual-chamber pacing. While leadless pacing technology has been developed over the years, its clinical application is currently limited to ventricular leadless pacing. However, because ventricular pacing is a non-physiological process, long-term use (especially right ventricular apex pacing) can lead to pacemaker syndrome, causing cardiac deterioration and harming the patient's health. This limits the widespread clinical application of leadless pacing technology. Summary of the Invention

[0005] This application provides an atrial implantation device, which includes: a pacing device comprising a pulse generating module, a first electrode, and a housing, wherein the pulse generating module is housed in the housing, the first electrode is configured to contact an atrial septum, and the pulse generating module is configured to deliver pacing pulses to the atrial septum through the first electrode; and an anchoring device configured to anchor the housing to the atrial septum.

[0006] In some embodiments, part or all of the housing constitutes the second electrode of the pacing device.

[0007] In some embodiments, the anchoring device includes a shunt configured to connect the left and right atria through an opening in the atrial septum, and the pacing device is mounted on the shunt.

[0008] In some embodiments, the shunt device includes a shunt member that forms a shunt pathway for connecting the left and right atria, wherein the pacing device further includes a second electrode, all or part of which constitutes the second electrode.

[0009] In some embodiments, the shunt device includes a shunt element and a mesh frame, the shunt element forming a shunt path for connecting the left and right atria, and the mesh frame covering the housing and the shunt element.

[0010] In some embodiments, the pacing device further includes a second electrode, all or part of which constitutes the second electrode.

[0011] In some embodiments, the atrial implantation device further includes a spacer disposed between the first electrode and the mesh frame to electrically space the first electrode from the mesh frame.

[0012] In some embodiments, the shunt device includes a shunt member forming a first opening, a second opening, and a shunt path extending therebetween, the first opening being configured in the left atrium of the patient and the second opening being configured in the right atrium of the patient, wherein the first opening is configured to be close to the front of the patient's head and body relative to the second opening.

[0013] In some embodiments, the anchoring device includes a occlusion device disposed at and occludes the opening of the atrial septum, wherein the housing is mounted on the occlusion device.

[0014] In some embodiments, the atrial implantation device further includes a data acquisition device for acquiring cardiac activity information of the patient, wherein the anchoring device is configured to anchor the data acquisition device to the atrial septum.

[0015] In some embodiments, the housing is disposed in the right atrium. The atrial implantation device provided in this application utilizes an anchoring device to anchor the housing of the pacing device to the patient's atrial septum, and uses electrodes in contact with the atrial septum to deliver pacing pulses directly to the patient's atrial septum. In this way, atrial pacing can be achieved, and the pacing effect is better. Attached Figure Description

[0016] To more clearly illustrate the technical solutions of the embodiments of this application, the accompanying drawings used in the embodiments will be briefly described below.

[0017] It should be understood that the following figures only show some embodiments of this application and should not be regarded as a limitation of the scope. For those skilled in the art, other related figures can be obtained from these figures without creative effort.

[0018] It should be understood that the same or similar reference numerals are used in the accompanying drawings to represent the same or similar components. It should also be understood that the drawings are schematic only, and the dimensions and scale of the components in the drawings are not necessarily precise.

[0019] Figure 1 This is a schematic diagram of an atrial implantation device according to an embodiment of this application.

[0020] Figure 2This is a schematic diagram of a pacing device according to an embodiment of this application.

[0021] Figure 3 This is a schematic diagram of an atrial implantation device according to another embodiment of this application.

[0022] Figure 4 This is a schematic diagram of a diversion component according to an embodiment of this application.

[0023] Figure 5 for Figure 4 Another schematic diagram of the flow divider in the process.

[0024] Figure 6 for Figure 4 Another schematic diagram of the flow divider in the process.

[0025] Figure 7 This is a schematic diagram of an atrial implantation device according to another embodiment of this application. Detailed Implementation

[0026] The embodiments of this application are illustrated below with reference to the accompanying drawings. It should be understood that there are various ways to implement this application, and it should not be construed as being limited to the embodiments described herein. The embodiments described herein are only for a more thorough and complete understanding of this application.

[0027] Figure 1 This is a schematic diagram of an atrial implantation device 10 according to an embodiment of this application. Figure 2 This is a schematic diagram of a pacemaker 11 according to an embodiment of this application.

[0028] It should be noted that in the accompanying drawings of the embodiments of this application, RA represents the patient's right atrium, LA represents the patient's left atrium, and AS represents the patient's atrial septum.

[0029] See Figure 1 and Figure 2 The atrial implantable device 10 includes a pacemaker 11 and an anchoring device 12. The pacemaker 11 and the anchoring device 12 are configured to be implanted in the atrium of a patient.

[0030] The pacemaker 11 includes a housing 111, a pulse generation module 112, and a first electrode 113. The pulse generation module 112 is housed within the housing 111. The pulse generation module 112 is used to sense the electrocardiogram (ECG) and to generate and transmit pacing pulses. The first electrode 113 is configured to contact the patient's atrial septum. The first electrode 113 and the second electrode form a sensing and pacing circuit. The sensing module senses the ECG activity of the atrial septum through this circuit, and the pacing pulses generated by the pulse generation module 112 are delivered to the patient's atrial septum through this circuit.

[0031] The anchoring device 12 is configured to be positioned on the patient's atrial septum AS and to anchor the housing 111 of the pacing device 11 to the patient's atrial septum.

[0032] The atrial implantation device provided in this application utilizes an anchoring device to anchor the pacemaker housing to the patient's atrial septum, and uses electrodes in contact with the atrial septum to deliver pacing pulses directly to the patient's atrial septum. In this way, atrial pacing can be achieved with superior pacing efficacy.

[0033] In some embodiments, see Figure 1 The anchoring device 12 is configured to penetrate the patient's atrial septum and has a first portion 121 located in the right atrium and a second portion 122 located in the left atrium. The first portion 121 forms a receiving space 121a, in which the housing 111 is received. The first electrode 113 may also directly contact the atrial septum on its left side, and the spacer 13 may also be located between the atrial septum and 122, electrically isolating the spacer 113. The spacer 13 may also be part of 122, for example, as a cover with electrically insulating properties on its surface.

[0034] In this way, the pacemaker housing can be anchored to the patient's atrial septum via an anchoring device.

[0035] It should be understood that, although in the above embodiments the anchoring device forms a receiving space and the pacemaker housing is housed within this receiving space, in other embodiments the anchoring device may not form a receiving space. For example, in some embodiments, the pacemaker housing may be connected to the anchoring device by fasteners.

[0036] In some embodiments, see Figure 1 and Figure 2 The pacing device 11 also includes a second electrode 114. Exemplarily, the first electrode 113 is a cathode and the second electrode 114 is an anode. The first electrode 113 may be in direct and stable contact with the atrial septum (e.g., by pressure from the septum 13, which may be directly from the septum 13 or generated by the second portion 122 through the septum 13), or it may be fixed to the atrial septum by a spiral mechanism on the second portion 122.

[0037] Part or all of the anchoring device 12 constitutes the second electrode 114. Alternatively, the second electrode 114 is integrally formed with the anchoring device 12. That is, the anchoring device 12 is used both to anchor the pacemaker 11 to the patient's atrial septum and to serve as one of the electrodes of the pacemaker.

[0038] By using part or all of the anchoring device as an electrode for the pacing device, a separate electrode is no longer necessary. This simplifies the structure of the atrial implantation device. Complex structures increase the adhesion of blood-borne debris and tissue hyperplasia, which may relatively increase the incidence of adverse reactions.

[0039] It should be understood that in other embodiments, the anchoring device may not be used as the second electrode. For example, a separate second electrode may be provided. Alternatively, the second electrode may be part or all of the pacemaker housing.

[0040] In some embodiments, see Figure 1 The atrial implantation device 10 also includes a spacer 13. The spacer 13 is located between the first electrode 113 and the anchoring device 12 (i.e., the second electrode 114). The spacer 13 may be made of an insulating material to electrically separate the first electrode 113 and the anchoring device 12 (i.e., the second electrode 114).

[0041] In this way, direct contact (direct electrical connection) between the two electrodes can be avoided.

[0042] It should be understood that the present application does not specifically limit the formation and size of the spacer 13, as long as it can electrically separate the first electrode 113 and the anchor 12 to avoid direct contact between them.

[0043] In some embodiments, see Figure 1 The anchoring device 12 has a grid structure.

[0044] Most cardiac implants have a mesh structure. Clinical studies have shown that mesh structures are less likely to cause adverse reactions. Therefore, using anchoring devices with a mesh structure can reduce the impact of implanted atrial devices on atrial physiological function and lower the likelihood of adverse reactions.

[0045] Optionally, in embodiments where the anchoring device has a grid structure, the outer side of the anchoring device may be covered with a coating layer that facilitates endothelialization, thereby accelerating the formation of endothelialization.

[0046] Optionally, in embodiments where the anchoring device serves as the second electrode and the covering layer is made of an insulating material, the anchoring device may have an exposed portion of blood directly exposed to the atrium that is not covered by the covering layer, or the anchoring device may be connected to a conductive element that is conductive and in direct contact with the blood in the atrium to achieve the function of serving as the second electrode.

[0047] In some embodiments, see Figure 1 and Figure 2 The housing 111 of the pacemaker 11 is configured to be located in the right atrium of the patient.

[0048] Placing the pacemaker housing in the patient's right atrium reduces the space occupied by the implanted device in the left atrium. Because of the higher pressure in the left atrium, the portion of the implanted device placed there is more prone to turbulence, potentially inducing thrombosis. Therefore, reducing the space occupied by the implanted device in the left atrium minimizes its impact on blood flow, thereby lowering the risk of thrombosis.

[0049] It should be noted that, in other embodiments, the housing of the pacemaker may also be configured in the patient's left atrium.

[0050] Figure 3 This is a schematic diagram of an atrial implantation device 20 according to another embodiment of this application.

[0051] The atrial implantation device 20 and the atrial implantation device 10 have many of the same elements. For the sake of brevity, the same elements are referred to by the same reference numerals and the corresponding descriptions are omitted.

[0052] See Figure 3 The atrial implantable device 20 includes a shunt device 22. The shunt device 22 is disposed at the opening of the atrial septum in the patient. The shunt device 22 is used to connect the left atrium and the right atrium through the opening in the atrial septum.

[0053] The pacemaker housing 111 is mounted on the shunt device 22, thereby anchoring it to the patient's atrial septum. In other words, the anchoring device of the atrial implantation device 20 is the shunt device 22. The shunt device 22 is used both to connect the patient's left and right atria through an opening in the patient's atrial septum and to anchor the pacemaker housing 111 to the patient's atrial septum.

[0054] For heart failure patients with persistent left atrial hypertension, an opening can be created in the atrial septum through a stoma procedure, and an atrial shunt device can be installed at the opening to connect the patient's left and right atria. This allows blood in the left atrium to be diverted to the right atrium, reducing the pressure in the left atrium and alleviating heart failure symptoms.

[0055] In some cases, these patients also require pacing therapy. If a traditional pacing device is used, the patient needs to purchase and implant the device separately, which increases treatment costs. Furthermore, traditional pacing devices require a separate anchoring device to be anchored to the patient's heart tissue, which can cause additional damage to the heart.

[0056] The atrial implantable device provided in this application combines shunt and pacing functions, eliminating the need for patients to purchase and implant separate shunt and pacing devices, thus reducing treatment costs. Furthermore, this application uses the shunt device as an anchoring device, avoiding additional damage to the patient's heart tissue for anchoring the pacing device, thereby benefiting the patient's health.

[0057] In some embodiments, see Figure 3 The shunt device 22 includes a shunt member 221. The shunt member 221 forms a first opening 221a, a second opening 221b, and a shunt path 221c extending between the two (i.e., between the first opening 221a and the second opening 221b). The first opening 221a is configured to be located in the left atrium of the patient, and the second opening 221b is configured to be located in the right atrium of the patient, thereby connecting the left and right atria of the patient.

[0058] In some embodiments, see Figure 3 The second electrode of the pacemaker 11 can be integrally formed with the shunt 221. In other words, part or all of the shunt 221 constitutes the second electrode of the pacemaker 11. That is to say, the shunt 221 is used both to realize the shunt function and to serve as an electrode of the pacemaker 11.

[0059] By using part or all of the shunt as an electrode in the pacing device, a separate electrode is no longer necessary. This simplifies the structure of the atrial implantation device. Complex structures increase the adhesion of blood-borne debris and tissue hyperplasia, which can potentially lead to adverse reactions.

[0060] In some embodiments, see Figure 3 The shunt device 22 may also include a mesh frame 222. The mesh frame 222 covers the housing 111 of the shunt 221 and the pacemaker 11.

[0061] The space frame 222 can be integrally formed with the diversion component 221, or the space frame 222 and the diversion component 221 can be two separate components. The embodiments of the application do not specifically limit this.

[0062] By using a mesh frame, the position and orientation of the shunt can be better secured. Furthermore, most penetrating atrial shunt devices employ a mesh frame structure, and clinical studies have shown that this structure is less likely to cause adverse reactions. Therefore, encasing the shunt and pacemaker within a mesh frame can reduce the impact of the shunt on atrial physiological function and lower the likelihood of adverse reactions.

[0063] It should be noted that in some embodiments, the diversion device may not include the grid frame. It should also be noted that in some embodiments, the diversion member may extend beyond the grid frame, such that the first opening and the second opening are located outside the grid frame.

[0064] In some embodiments, see Figure 3 The second electrode of the pacemaker 11 can be integrally formed with the mesh frame 222. In other words, part or all of the mesh frame 222 constitutes the second electrode of the pacemaker 11.

[0065] Using part or all of the mesh structure as electrodes for the pacing device eliminates the need for a separate electrode. This simplifies the structure of atrial implantation devices. Complex structures increase the adhesion of blood-borne debris and tissue hyperplasia, which can potentially lead to adverse reactions.

[0066] In some embodiments, see Figure 3 The atrial implantation device 22 also includes a spacer 23. The spacer 23 is located between the first electrode 113 and the mesh frame 222 (i.e., the second electrode), thereby electrically separating the first electrode 113 and the mesh frame 222 (i.e., the second electrode).

[0067] In some embodiments, see Figure 3 The spacer 23 is located between the first electrode 113 and the shunt of the right atrium or the left atrium, thereby electrically separating the first electrode 113 from other structures of the implant.

[0068] In this way, direct contact between the two electrodes can be avoided.

[0069] In some embodiments, see Figure 3 The housing 111 of the pacemaker 11 is positioned in the patient's right atrium.

[0070] Because the mesh frame encloses the pacemaker's housing, placing the housing in the patient's right atrium reduces the space occupied by the portion of the mesh frame located in the left atrium. Since implants in the left atrium are more prone to causing turbulence and thrombosis, this method reduces the risk of thrombosis.

[0071] In some embodiments, see Figure 3 The atrial implantable device 20 also includes a data acquisition device 24. The data acquisition device 24 is used to acquire information about the patient's heart activity. For example, the information about the heart activity may include, but is not limited to, one or more of the following: blood pressure, blood flow rate, blood pH, blood temperature, blood oxygen, heart sounds, and cardiac contractility.

[0072] The acquisition device 24 is mounted on the shunt device 22 (i.e., the anchoring device) and thus anchored to the patient's atrial septum. It should be understood that, although in Figure 3 In this embodiment, the acquisition device 24 is located in the left atrium, but in other embodiments, the acquisition device 24 may also be located in the right atrium.

[0073] It should also be understood that, although in Figure 3In this embodiment, the data acquisition device 24 is mounted on the grid frame 222, but in other embodiments, the data acquisition device 24 may also be mounted in other locations. For example, in some embodiments, the data acquisition device 24 may be mounted on the shunt member 221. Also, in some embodiments, the data acquisition device 24 may be mounted on the housing 111 of the pacemaker 11.

[0074] It should be understood that, Figure 1 In the illustrated embodiment, the atrial implantation device 10 may also include a data acquisition device, which may be mounted, for example, on the anchor 12 or on the housing 111 of the pacemaker 11.

[0075] The data acquisition device can collect atrial activity information from a patient, thereby monitoring the patient's health status, such as hemodynamic information. Using the same anchoring device to separately anchor the pacemaker and the data acquisition device eliminates the need for separate anchoring devices for each device, thus avoiding additional damage to cardiac tissue caused by multiple anchoring devices.

[0076] Figure 4 This is a schematic diagram of a diversion member 221 according to an embodiment of this application. Figure 5 and Figure 6 for Figure 4 A schematic diagram of the flow divider 221 in other view directions. Figure 5 The view direction is the view direction from the left to the right of the patient when the patient is in an upright position. Figure 6 The view direction is the view from the patient's left side to the right side when the patient is in a supine position. Figure 5 and Figure 6 In the diagram, the solid line portion of the shunt 221 represents the portion placed in the patient's left atrium, and the dashed line portion represents the portion placed in the patient's right atrium.

[0077] In some embodiments, reference Figures 4 to 6 When the shunt 221 is installed in the patient's atrium, the first opening 221a can be configured to be close to the front of the patient's head and body relative to the second opening 221b.

[0078] If the first opening 221a is closer to the front of the patient's head and body than the second opening 221b, then when the patient is in an upright or supine position (or a position close to an upright or supine position), the first opening 221a is higher than the second opening 221b in terms of gravity, so that blood and / or suspended matter (such as microthrombi) in the right atrium need to overcome gravity to reach the left atrium.

[0079] Therefore, when the patient is in an upright or supine position (or a position similar to an upright or supine position), the shunt 221 provided in this embodiment can effectively prevent or reduce the flow of blood and / or suspended matter in the blood from the right atrium to the left atrium, and this method avoids the problem of pathway blockage compared to installing a valve. Considering that people spend most of their time in an upright or supine position (or a position similar to an upright or supine position) in daily life, the shunt 221 provided in this embodiment can meet the needs of patients' daily activities.

[0080] In some embodiments, reference Figures 4 to 6 When the shunt 221 is installed in the patient's atrium, the first opening 221a can be configured to be close to the front of the patient's head and body relative to the opening H on the interatrial septum, and the second opening 221b can be configured to be close to the patient's feet and the back of the body relative to the opening H on the interatrial septum.

[0081] To describe this implementation more clearly and accurately, a hypothetical Cartesian coordinate system is constructed to provide another perspective. This coordinate system uses the plane containing the atrial septum (AS) as its reference plane, the location of the opening H on the atrial septum as its origin, the intersection of the horizontal plane passing through the opening H and the plane containing the atrial septum (AS) when the patient is in an upright position as the x-axis, the direction from the back of the patient's body to the front as the positive direction of the x-axis, the straight line passing through the origin on the reference plane and perpendicular to the x-axis as the y-axis, and the direction from the patient's feet to the head as the positive direction of the y-axis.

[0082] It should be understood that the atrial septum of a patient is not an ideal plane; it has a certain thickness and is not absolutely flat. However, for the sake of describing the embodiments of this application as clearly as possible, the atrial septum can be considered to lie on a certain plane. For example, the plane on which the atrial septum lies can be the plane with the highest degree of overlap with the atrial septum. For example, the plane on which the atrial septum lies can also be a fitted plane (or an imaginary plane) where the sum of the distances (shortest distances) from all points of the atrial septum to the plane is minimized.

[0083] When the shunt 221 is installed in the patient's atrium, the first opening 221a can be configured such that its orthographic projection on the plane of the atrial septum is located in the first quadrant of the coordinate system, and the second opening 221b can be configured such that its orthographic projection on the plane of the atrial septum is located in the third quadrant of the coordinate system.

[0084] like Figure 5 As shown, when the patient is in an upright position, the first opening 221a is higher than the second opening 221b in the direction of gravity (i.e., the direction indicated by the thick arrow in the figure).

[0085] like Figure 6As shown, when the patient is in a supine position, the first opening 221a is also higher than the second opening 221b in the direction of gravity (i.e., the direction indicated by the thick arrow in the figure).

[0086] Therefore, this method allows the first opening to be closer to the front of the patient's head and body than the second opening, thus effectively preventing or reducing the flow of blood and / or suspended matter in the blood from the right atrium to the left atrium when the patient is in an upright or supine position (or a position close to supine or upright).

[0087] It should be understood that the shunt device in the above embodiments is merely an exemplary implementation. This application does not specifically limit the implementation of the shunt device, as long as it can achieve the function of connecting the left and right atria of the patient. In some embodiments, the shunt device in this application may also be a conventional shunt device.

[0088] Figure 7 This is a schematic diagram of an atrial implantation device 30 according to another embodiment of this application.

[0089] The atrial implantation device 30 and the atrial implantation device 10 share many of the same elements. For the sake of brevity, the same elements are referred to by the same reference numerals and their descriptions are omitted.

[0090] See Figure 7 The atrial implantation device 30 includes an occlusion device 32. The occlusion device 32 is disposed at the opening of the patient's atrial septum. The occlusion device 32 is used to block the opening in the patient's atrial septum, thereby preventing communication between the patient's left and right atria.

[0091] The housing 111 of the pacemaker 11 is mounted on the occlusion device 32, thereby anchoring it to the patient's atrial septum. In other words, the anchoring device of the atrial implantation device 30 is the occlusion device 32. The occlusion device 32 is used both to block the opening in the patient's atrial septum and to anchor the housing 111 of the pacemaker 11 to the patient's atrial septum.

[0092] It should be understood that, although in Figure 7 In this embodiment, the housing 111 of the pacemaker 11 is disposed in the right atrium of the patient, but in other embodiments, the housing 111 of the pacemaker 11 may also be disposed in the left atrium of the patient.

[0093] It should also be understood that in other embodiments, the atrial implantation device 30 may also include a data acquisition device, which may be mounted on the occlusion device 32 or on the housing 111 of the pacemaker 11.

[0094] For patients with atrial septal defects, a closure device can be placed at the opening of the atrial septum to block blood flow between the left and right atria and restore normal blood circulation.

[0095] In some cases, these patients also require pacing therapy. If a traditional pacing device is used, the patient needs to purchase and implant the device separately, which increases treatment costs. Furthermore, traditional pacing devices require a separate anchoring device to be anchored to the patient's heart tissue, which can cause additional damage to the heart.

[0096] The atrial implantable device provided in this application combines occlusion and pacing functions, eliminating the need for patients to purchase and implant separate occlusion and pacing devices, thereby reducing treatment costs. Furthermore, this application uses the occlusion device as an anchoring device, avoiding additional damage to the patient's heart tissue for anchoring the pacing device, thus benefiting the patient's health.

[0097] It should be understood that the occlusion device in the above embodiments is merely an exemplary implementation. This application does not specifically limit the implementation of the occlusion device, as long as it can block the opening in the patient's atrial septum. In some embodiments, the occlusion device in this application may also be a conventional occlusion device.

[0098] It should be understood that the term "comprising" and its variations as used in this application are open-ended, meaning "including but not limited to". The term "one embodiment" means "at least one embodiment"; the term "another embodiment" means "at least one additional embodiment".

[0099] It should be understood that although terms such as “first” or “second” may be used in this application to describe various elements (such as the first opening and the second opening of the diversion element), these elements are not limited by these terms, which are only used to distinguish one element from another.

[0100] The above description is merely a specific embodiment of this application, but the scope of protection of this application is not limited thereto. Any variations or substitutions that can be easily conceived by those skilled in the art within the scope of the technology disclosed in this application should be included within the scope of protection of this application. Therefore, the scope of protection of this application should be determined by the scope of the claims.

Claims

1. An atrial implantation device, characterized in that, include: A pacing device includes a pulse generating module, a first electrode, and a housing. The pulse generating module is housed in the housing. The first electrode is configured to contact an atrial septum. The pulse generating module is configured to deliver pacing pulses to the atrial septum through the first electrode. The pulse generating module is used to sense electrocardiograms and generate the pacing pulses. as well as An anchoring device configured to anchor the housing to the atrial septum, the anchoring device including a shunt device configured to connect the left and right atria through an opening in the atrial septum, the pacing device being mounted on the shunt device.

2. The atrial implantation device according to claim 1, characterized in that, Part or all of the housing constitutes the second electrode of the pacing device, the first electrode is used to form a sensing and pacing circuit with the second electrode; the pulse generation module is used to sense the electrocardiogram and generate the pacing pulse.

3. The atrial implantation device according to claim 1, characterized in that, The shunt device includes a shunt element that forms a shunt pathway connecting the left and right atria, wherein the pacing device further includes a second electrode, and the first electrode is used to form a sensing and pacing circuit with the second electrode; all or part of the shunt element constitutes the second electrode.

4. The atrial implantation device according to claim 1, characterized in that, The shunt device includes a shunt element and a mesh frame. The shunt element forms a shunt path for connecting the left and right atria, and the mesh frame covers the housing and the shunt element.

5. The atrial implantation device according to claim 4, characterized in that, Part or all of the mesh structure constitutes the second electrode, and the first electrode is used to form a sensing and pacing circuit with the second electrode.

6. The atrial implantation device according to claim 5, characterized in that, The atrial implantation device further includes a spacer disposed between the first electrode and the mesh frame to electrically space the first electrode from the mesh frame; the first electrode is maintained in contact with the atrial septum by pressure from the spacer.

7. The atrial implantation device according to claim 1, characterized in that, The shunt device includes a shunt member forming a first opening, a second opening, and a shunt path extending between them. The first opening is disposed in the left atrium of the patient, and the second opening is disposed in the right atrium of the patient. The first opening is configured to be close to the front of the patient's head and body relative to the second opening. The shunt device also includes a mesh frame, and the shunt member extends beyond the mesh frame such that the first and second openings are located outside the mesh frame.

8. The atrial implantation device according to any one of claims 1 to 7, characterized in that, The atrial implantation device further includes a data acquisition device for acquiring cardiac activity information of the patient, including one or more of blood pressure, blood flow rate, blood pH, blood temperature, blood oxygen, heart sounds, and cardiac contractility; or the data acquisition device is used to acquire atrial activity information of the patient, including hemodynamic information, wherein the anchoring device is configured to anchor the data acquisition device to the atrial septum; the data acquisition device is mounted on the shunt element of the shunt device, or the data acquisition device is mounted on the housing of the pacemaker.

9. The atrial implantation device according to claim 1, characterized in that, The shell is disposed in the right atrium; The anchoring device has a first portion configured to be located in the right atrium and a second portion configured to be located in the left atrium; the first portion forms a receiving space in which the housing is received, or the housing is connected to the anchoring device by fasteners; The anchoring device has a grid structure; The anchoring device is covered by a coating layer that facilitates endothelialization; the coating layer is made of an insulating material; the anchoring device also has an exposed portion that is not covered by the coating layer and is directly exposed to blood in the atrium; or, the anchoring device is connected to a conductive element that is in direct contact with blood in the atrium to function as a second electrode, wherein the first electrode is used to form a sensing and pacing circuit with the second electrode.

Citation Information

Patent Citations

  • Atrial implant device

    CN219001761U

  • Trans septal implantable medical device

    US20170326369A1